Media Resources

Every day, hundreds of thousands of scientists across the globe use Life Technologies’ products and services to advance science in fields as diverse as personalized medicine, 21st century forensics, and biofuels. Here is contact information for members of the media to use for more information about how our company and products are used to innovate in science.

Media Contacts

Farnaz Khadem

Life Technologies
Senior Director, Corporate Communications and Public Relations
P (760) 603-7245

Mark Springer

Life Technologies
Technical Public Relations,
Molecular Biology
P (650) 638-6113

Tim Ingersoll

Life Technologies
Corporate Media Relations
P (760) 918-3883

Lauren Lum

Life Technologies
Technical Public Relations,
Cell Systems Division, Applied Markets
P (650) 638-6916

Kim Evans

Life Technologies
Corporate Communications | Social Media
P (760) 476-7816

Patty Zamora

Life Technologies
Technical Public Relations,
Genomics, DNA Sequencing
P (760) 476-7818

Eriko Takahata

Life Technologies
Communications, Japan

Vivian Lv

Life Technologies
Communications, Asia Pacific

News

  • TGen Study

    LifeTechnologies Corporation announced that it is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies. The goal of this first-of-its-kind research collaboration is to demonstrate whether genomic sequencing of cancer tissue can provide clues for treatment strategies for these individuals.

    Read All Close
  • SMS Technology

    Life Technologies Corporation announced early stage results from its single molecule sequencing (SMS) technology. The technology promises to combine virtually unlimited continuous long read lengths with unmatched accuracy to deliver targeted genomic sequence data in a matter of hours, paving the way for sequencing to become a commonplace tool in research laboratories and clinical settings worldwide.

    Read All Close
  • SOLiD PI ANNOUNCED

    Life Technologies Corporation today announced plans for the Applied Biosystems SOLiD(TM) PI System, a new highly accurate, flexible and easy-to-use genomic analysis platform that will bring next-generation sequencing within the grasp of all life science research laboratories worldwide. Early customer adoption of the SOLiD PI System is expected to begin in the second half of 2010.

    Read All Close

Life (Common Stock)